Joint Corp. (JYNT)
10.28
-0.05 (-0.48%)
At close: Jan 14, 2025, 3:59 PM
10.22
-0.58%
After-hours Jan 14, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 9.1 |
| Market Cap | 154.03M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.17 |
| PE Ratio (ttm) | -8.79 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 14.96 |
| Volume | 36,849 |
| Avg. Volume (20D) | 48,722 |
| Open | 10.32 |
| Previous Close | 10.33 |
| Day's Range | 10.11 - 10.56 |
| 52-Week Range | 8.94 - 17.82 |
| Beta | undefined |
About JYNT
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona....
Industry Medical - Care Facilities
Sector Healthcare
IPO Date Nov 11, 2014
Employees 444
Stock Exchange NASDAQ
Ticker Symbol JYNT
Website https://www.thejoint.com
Analyst Forecast
According to 2 analyst ratings, the average rating for JYNT stock is "Buy." The 12-month stock price forecast is $17.5, which is an increase of 70.23% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
Next Earnings Release
Joint Corp. is scheduled to release its earnings on Mar 6, 2025,
during market hours.
Analysts project revenue of $28.95M, reflecting a -5.44% YoY shrinking and earnings per share of 0.06, making a -108.00% decrease YoY.
Analysts project revenue of $28.95M, reflecting a -5.44% YoY shrinking and earnings per share of 0.06, making a -108.00% decrease YoY.
8 months ago ·
Source
+25.35%
Joint shares are trading higher after the company ...
Unlock content with
Pro Subscription
10 months ago ·
Source
+29.98%
Joint shares are trading higher after the company reported Q4 financial results.
